BioSpace News Archive

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the company will participate in the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021.

Abbott will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021. Robert B. Ford, president and chief executive officer, will present at 9 a.m. Central time.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer announced today that it has entered into a license agreement with SciClone Pharmaceuticals International Ltd (“SciClone”) to be the exclusive co-development and commercialization partner of the Company’s antibodies, DANYELZA

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office granted Natera a significant win when it denied a patentability challenge from a multi-national sequencing company against Natera’s U.S. Patent No. 8,682,592 (‘592 Patent) upholding all claims.

Tumor board discussions will analyze treatment landscapes, clinical study findings and emerging treatment options for genitourinary cancers.

DxTerity Diagnostics is pleased to announce a strategic collaboration with Amazon to distribute its SARS-CoV-2 diagnostic tests to U.S. small businesses and customers at home

SwiveLock® ACL Repair Kit designed as a less-invasive treatment method for certain types of anterior cruciate ligament tears

The global market for non-invasive prenatal testing is expected to grow at a significant pace in the next few years.

The global airway management devices are medical devices used for patients have obstructed airways or are at the risk of being obstructed.

Critical care settings are a resource-intensive environment which has seen the use of wide range of patient monitoring products of which clinical informatics is a key issue.